| |
Thomas H Brannagan III, MD
Associate Professor of Clinical Neurology
Director, Peripheral Neuropathy Center
Columbia University College of Physicians and Surgeons
Co-director, Electromyography Laboratory
NewYork-Presbyterian Hospital
Columbia University Medical Center
Education:
- Undergraduate: University of Virginia
- MD: University of Virginia
- Residency: Neurology, Columbia-Presbyterian Medical Center
- Fellowship: (EMG and Neuromuscular Disease) Columbia Presbyterian Medical Center
- Fellowship: (Neuroimmunology) Columbia Presbyterian Medical Center
Board Certification:
Neurology, Clinical Neurophysiology and Electrodiagnostic Medicine
Office Location:
710 W 168th St
New York, NY 10032
Phone: (212) 305-0405
EMG appointments: (212) 305-1330
Fax: (212) 305-5396
Insurance: Aetna, CIGNA, Empire BC/BS-Wellchoice & Unicare, Oxford, PHS/Healthnet, United Healthcare, Medicare, Medicaid
*Please verify insurance participation with the physician's office when making an appointment.
» http://columbianeuropathy.org
» http://columbiaemg.org
Dr. Brannagan is the director of the Peripheral Neuropathy Center at Columbia University Medical Center. He graduated from the University of Virginia and also received his medical degree from the University of Virginia in Charlottesville. He completed his Neurology residency training at the Neurological Institute of Columbia Presbyterian Medical Center between 1991 and 1994. He subsequently did a Neuromuscular EMG fellowship at Columbia, followed by a Neuroimmunology fellowship in the laboratory of Dr. Norman Latov. Prior to returning to Columbia, Dr. Brannagan was the director of the Diabetic Neuropathy Research center at Cornell University in New York City and was co-director of the EMG laboratory at MCP-Hahnemann University in Philadelphia.
He is a member of the American Academy of Neurology, as well as the American Association of Electrodiagnostic Medicine. He is also a member of the Neuropathy Association and the Peripheral Nerve Society.
Dr. Brannagan's major interest is in the evaluation and treatment of peripheral neuropathy, particularly immune-mediated neuropathies and diabetic neuropathies. His publications have focused on new treatments for chronic demyelinating polyneuropathy (CIDP), painful neuropathies, neuropathy associated with celiac disease and the use of IVIg in Neurological disorders. He has participated in numerous clinical trials of new agents to treat patients with peripheral neuropathy.
Selected Recent publications:
Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.
De Sousa EA, Chin RL, Sander HW, Latov N, Brannagan TH 3rd.
J Clin Neuromuscul Dis. 2009 Jun;10(4):163-9.
PMID: 19494726 [PubMed - indexed for MEDLINE]
Current treatments of chronic immune-mediated demyelinating polyneuropathies.
Brannagan TH 3rd.
Muscle Nerve. 2009 May;39(5):563-78. Review.
PMID: 19301378 [PubMed - indexed for MEDLINE]
Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee. Donofrio PD, Berger A, Brannagan TH 3rd, Bromberg MB, Howard JF, Latov N, Quick A, Tandan R.
Gorson KC, Herrmann DN, Thiagarajan R, Kinsella L, Brannagan TH, Chin RL, Ropper AH. Non-Length Dependent Small Fiber Neuropathy/ Ganglionopathy. J Neurol Neurosurg Psychiatry. 2008;79:163-169.
Neuroimmunology in clinical practice. Kalman B, Brannagan TH, editors. Blackwell. Oxford, 2008, 263 pages.
Toothaker TB, Brannagan TH. Chronic inflammatory demyelinating polyneuropathies: Current treatment strategies. Current Neurology and Neuroscience Reports. 2007;7:63-70.
Gondim FAA, de Sousa EA, Latov N, Sander HW, Chin RL, Brannagan TH.
Anti-MAG/SGPG associated neuropathy does not commonly cause distal nerve temporal dispersion. J Neurol Neurosurg Psychiatry. 2007;78:902-904.
Gladstone DE, Golightly MG, Brannagan TH. High Dose Cyclophosphamide Preferentially Targets Naive T (CD45/CD4/RA+) Cells in CIDP and MS Patients. J Neuroimmunology. 2007;190:121-126.
Souayah N, Seltzer, Chin RL, Brannagan TH, Sander HW. Rare Myelin Protein Zero Sequence Variant in Late Onset CMT1B. Journal of the Neurological Sciences. 2007;263:177-179.
Brannagan TH III, Alaedini A, Gladstone DE. High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy. Muscle Nerve. 2006;34:246-250.
de Sousa EA, Hays AP, Chin RL, Sander HW, Brannagan TH III. Characteristics of sensory neuropathy patients diagnosed with abnormal small nerve fibers on skin biopsy. J Neurol Neurosurg Psychiatry. 2006;77:983-985.
Chin RL, Tseng VG, Green PHR, Sander HW, Brannagan TH, Latov N. Multifocal axonal polyneuropathy in celiac disease. Neurology 2006;66:1923-1925.
Latov N, Gorson KC, Brannagan TH III, Freeman RL, Apostolski S, Berger AR, Bradley WG, Briani C, Bril V, Busis NA, Cros DP, Dalakas MC, Donofrio PD, Dyck PJB, England JD, Fisher MA, Herrmann DN, Menkes, DL, Sahenk Z, Sander HW, Triggs, WJ, Vallat JM. Diagnosis and treatment of chronic immune-mediated neuropathies. J Clin Neuromusc Dis 2006;7:141-157.
Brannagan TH, Hays AP, Chin SS, Sander HW, Chin RL, Green PHR, Latov N. Small fiber neuropathy-neuronopathy in celiac disease - skin biopsy findings. Arch Neurol. 2005 62:1574-1578.
Gondim FAA, Brannagan TH, Sander HW, Chin RL, Latov N. Peripheral neuropathy in patients with inflammatory bowel disease. Brain. 2005; 128: 867-879.
Brannagan TH, Weimer LH, Latov N. Acquired Neuropathies. In Rowland LP, editor. Merritt's Neurology. Lippincott Williams & Wilkins, 11th Edition. Lippincott, Williams and Wilkins. Philadelphia, 2005, chapter 106, pp 746-765.
|
© 2004 The Neurological Institute of New York • 710 W 168th St, New York, NY 10032
Department of Neurology | Columbia University Medical Center | Last updated:
August 28, 2009
| Comments |
|
|
